Literature DB >> 6324806

Mechanism of action of the phorbol ester tumor promoters: specific receptors for lipophilic ligands.

P M Blumberg, S Jaken, B König, N A Sharkey, K L Leach, A Y Jeng, E Yeh.   

Abstract

Cells and tissue preparations specifically bind the phorbol ester tumor promoters. The agreement in structure-activity relationships between binding and biological response strongly argues that these binding sites function as phorbol ester receptors. Upon subcellular fractionation, the phorbol ester binding activity is particulate. In addition, a phorbol ester apo-receptor can be detected in cytosol which requires phospholipids for reconstitution. This apo-receptor appears to correspond to protein kinase C. Diacylglycerols, the probable natural activators of protein kinase C, competitively inhibit phorbol ester binding, consistent with their being the postulated endogenous phorbol ester analogs. In certain systems, heterogeneity of phorbol ester binding is found. An outstanding issue therefore is whether protein kinase C is the phorbol ester receptor or whether it is only the most abundant class of receptor. Although this question remains unresolved, we can demonstrate heterogeneity of phorbol ester binding by reconstitution of apo-receptor into a heterogeneous lipid environment.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6324806     DOI: 10.1016/0006-2952(84)90448-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  38 in total

1.  PKC isoenzyme expression and cellular responses to phorbol ester in JEG-3 choriocarcinoma cells.

Authors:  A M Bamberger; C M Bamberger; M Wald; K Jensen; H M Schulte
Journal:  Endocrine       Date:  1997-04       Impact factor: 3.633

Review 2.  Activation and regulation of protein kinase C enzymes.

Authors:  G L Nelsestuen; M D Bazzi
Journal:  J Bioenerg Biomembr       Date:  1991-02       Impact factor: 2.945

3.  Cholinergic phosphatidylinositol modulation of inhibitory, G protein-linked neurotransmitter actions: electrophysiological studies in rat hippocampus.

Authors:  P F Worley; J M Baraban; M McCarren; S H Snyder; B E Alger
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

Review 4.  Protein kinase C as a tumor suppressor.

Authors:  Alexandra C Newton
Journal:  Semin Cancer Biol       Date:  2017-05-02       Impact factor: 15.707

5.  Computer-assisted molecular modeling of tumor promoters: rationale for the activity of phorbol esters, teleocidin B, and aplysiatoxin.

Authors:  A M Jeffrey; R M Liskamp
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

6.  Interaction of phorbol esters with Ca2+ channels in smooth muscle.

Authors:  M Spedding
Journal:  Br J Pharmacol       Date:  1987-06       Impact factor: 8.739

7.  The occurrence of protein kinase C theta and lambda isoforms in retina of different species.

Authors:  R McCord; A Klein; N N Osborne
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

8.  Regulation of megakaryocyte phenotype in human erythroleukemia cells.

Authors:  M W Long; C H Heffner; J L Williams; C Peters; E V Prochownik
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

9.  Inhibitory action of polyamines on protein kinase C association to membranes.

Authors:  M Moruzzi; B Barbiroli; M G Monti; B Tadolini; G Hakim; G Mezzetti
Journal:  Biochem J       Date:  1987-10-01       Impact factor: 3.857

10.  Alteration of protein kinase C activity in the postischemic rat brain areas using in vitro [3H]phorbol 12,13-dibutyrate autoradiography.

Authors:  H Nagasawa; T Araki; K Kogure
Journal:  J Neural Transm Gen Sect       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.